Want to see FR:BN full AI Analyst Report?
BN Stock Chart & Stats
€70.00
€0.82(1.17%)
At close: 4:00 PM EDT
€70.00
€0.82(1.17%)
Day’s Range― - ―
52-Week Range€60.64 - €80.14
Previous CloseN/A
Volume434.66K
Average Volume (3M)1.01M
Market Cap
€43.81B
Enterprise Value€55.30K
Total Cash (Recent Filing)€8.34B
Total Debt (Recent Filing)€17.43B
Price to Earnings (P/E)22.3
Beta0.16
Next Earnings
Feb 24, 2027EPS Estimate
2.03Next Dividend Ex-DateN/A
Dividend Yield3.31%
Share Statistics
EPS (TTM)3.05
Shares Outstanding683,337,160
10 Day Avg. Volume1,201,860
30 Day Avg. Volume1,009,219
Financial Highlights & Ratios
PEG Ratio-2.75
Price to Book (P/B)2.92
Price to Sales (P/S)1.81
P/FCF Ratio18.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€80.75Price Target Upside15.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)3.96
Revenue Forecast (FY)€28.22B
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationDurable operating and free cash flow provides Danone with recurring liquidity to fund capex, dividends, deleveraging and targeted M&A. Reliable cash generation supports financial resilience through commodity cycles and enables multi-year investments in innovation and distribution.
Manageable Leverage And Sizable Equity BaseModerate leverage for a global packaged-foods peer gives Danone financial flexibility to pursue strategic initiatives while keeping refinancing risk contained. A large equity base supports credit profile stability and capacity for disciplined acquisitions without aggressive gearing increases.
Health-focused Portfolio And Multi-engine ModelDanone’s emphasis on health-oriented categories (high-protein, medical nutrition, plant-based) aligns with persistent consumer trends toward healthier diets. A diversified, multi-engine model across geographies and channels reduces concentration risk and supports sustainable volume and pricing opportunities over the medium term.
Bears Say
Sharp Recent Revenue DeclineA steep one-year revenue contraction materially weakens top-line momentum and raises questions about sustainable demand and reported growth comparability. Recovering lost sales can take multiple quarters and may require sustained investment in marketing, pricing and product repositioning, pressuring near-term execution.
Volatile Profitability And MarginsWide swings in net margins reflect sensitivity to input costs, mix shifts and regional issues, undermining predictability of returns. Persistent margin volatility makes free cash flow and ROE outcomes less certain, complicating multi-year planning and investor visibility into durable profitability levels.
Regulatory Risk On Strategic M&AA CMA probe into the Huel deal introduces execution risk and potential remedies or divestitures. Regulatory barriers can delay or block market-entry strategies in fast-growing plant-based channels, reducing the expected strategic lift from acquisitions and increasing integration uncertainty.
DANONE SA News
BN FAQ
What was DANONE SA’s price range in the past 12 months?
DANONE SA lowest stock price was €60.64 and its highest was €80.14 in the past 12 months.
What is DANONE SA’s market cap?
DANONE SA’s market cap is €43.81B.
When is DANONE SA’s upcoming earnings report date?
DANONE SA’s upcoming earnings report date is Feb 24, 2027 which is in 197 days.
How were DANONE SA’s earnings last quarter?
DANONE SA released its earnings results on Jul 29, 2026. The company reported €1.92 earnings per share for the quarter, beating the consensus estimate of €1.883 by €0.037.
Is DANONE SA overvalued?
According to Wall Street analysts DANONE SA’s price is currently Undervalued.
Does DANONE SA pay dividends?
DANONE SA pays a Annually dividend of €2.25 which represents an annual dividend yield of 3.31%. See more information on DANONE SA dividends here
What is DANONE SA’s EPS estimate?
DANONE SA’s EPS estimate is 2.03.
How many shares outstanding does DANONE SA have?
DANONE SA has 683,337,160 shares outstanding.
What happened to DANONE SA’s price movement after its last earnings report?
DANONE SA reported an EPS of €1.92 in its last earnings report, beating expectations of €1.883. Following the earnings report the stock price went down -2.298%.
Which hedge fund is a major shareholder of DANONE SA?
Currently, no hedge funds are holding shares in FR:BN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DANONE SA
Danone S.A. is a major company within the food and beverage industry, conducting its operations across various global regions including Europe, North America (Noram), Latin America, Asia Pacific, Africa, and the Middle East. The company's business is organized into three principal segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Under its Essential Dairy & Plant-Based division, Danone manufactures and distributes a broad array of products. This range includes yogurts, diverse milk products, coffee creamers, a variety of drinks and beverages, plant-based alternatives, ice creams, desserts, and powdered nutritional protein items. These are sold under proprietary brands such as Actimel, Activia, Alpro, Danette, Danio, and Danonino, as well as licensed brands including International Delight, Dunkin' Donuts, and Bailey's. The Specialized Nutrition segment focuses on providing tailored nutritional offerings. This encompasses products developed for pregnant and breastfeeding mothers, infants, and young children, marketed under names like Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics. Additionally, this segment extends to medical nutrition, featuring tube feeding formulas (e.g., Nutrison), oral nutritional supplements (e.g., Fortimel, NutriDrink), and specialized hypoallergenic products for children with allergies (e.g., Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo). Within the Waters segment, Danone offers a portfolio of bottled water products, some of which are enhanced with natural fruit extracts, fruit juice, and vitamins. Key brands in this category include evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj. Danone distributes its wide selection of products through multiple channels. These include large retail chains, traditional market outlets, convenience stores, healthcare settings such like hospitals, clinics, and pharmacies, and increasingly, through e-commerce platforms. Incorporated in 1899, the company was initially known as Groupe Danone before officially changing its name to Danone S.A. in April 2009. Its corporate headquarters are situated in Paris, France.
BN Stock 12 Month Forecast
Average Price Target
€80.75
▲(15.36% Upside)









